PEPA


Sulfonamide AMPA potentiator

A potent benzothiazide AMPA potentiator used principally as a research probe for AMPA receptor pharmacology.

Abstract

PEPA (4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide; CAS 158235-23-7) is a potent sulfonamide-class AMPA receptor positive allosteric modulator developed as a research tool compound. The compound shows substantially greater AMPA potentiation per molecule than the marketed and Phase 2 ampakines, but with poor pharmacokinetic properties (low oral bioavailability, short plasma half-life) that limit clinical translation. PEPA is used principally as a research probe for AMPA receptor pharmacology in vitro and ex vivo. The compound has not been advanced to human clinical trials and has no significant research-chemical-grade availability outside academic research supply chains.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph